Showing results (2671-2680 of 9,906) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|October 3, 2019
Cubic splines to model relationships between continuous variables and outcomes: a guide for cliniciansJ Gauthier, Q V Wu, T A Gooley
Bone Marrow Transplantation|January 16, 2021
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trialR Pettengell, R Uddin, A Boumendil, et al.
Bone Marrow Transplantation|January 17, 2021
Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. studyRomain Lopez, Geneviève Plat, Yves Bertrand, et al.
Bone Marrow Transplantation|January 30, 2021
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced diseaseU Thiel, S J Schober, A Ranft, et al.
Bone Marrow Transplantation|January 30, 2021
Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomesSachin Punatar, Siddhesh A Kalantri, Akanksha Chichra, et al.
Bone Marrow Transplantation|August 1, 1987
Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemiasM C Favrot, P Hervé
Bone Marrow Transplantation|October 1, 1987
Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrowP De Fabritiis, A Pulsoni, A Sandrelli, et al.
Bone Marrow Transplantation|January 4, 2022
Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparinLina Stutz, Jörg P Halter, Dominik Heim, et al.
Bone Marrow Transplantation|January 20, 2022
The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001Esteve Trias, Manel Juan, Alvaro Urbano-Ispizua, et al.
Bone Marrow Transplantation|March 1, 1990
Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipientsB E De Pauw, J P Donnelly, T De Witte, et al.
Pageof 991